GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (FRA:PWE) » Definitions » Float Percentage Of Total Shares Outstanding

PW Medtech Group (FRA:PWE) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 08, 2024)


View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PW Medtech Group's float shares is 0.00 Mil. PW Medtech Group's total shares outstanding is 1,565.63 Mil. PW Medtech Group's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PW Medtech Group's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PW Medtech Group's Institutional Ownership is 0.50%.


PW Medtech Group Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

PW Medtech Group's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,565.63
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PW Medtech Group (FRA:PWE) Business Description

Industry
Traded in Other Exchanges
Address
Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

PW Medtech Group (FRA:PWE) Headlines

No Headlines